StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.20+0.01 (+0.08%)

Close on Nov 18, 2026Market cap $136.43MP/E –Yield 0.00%

Medifast revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Medifast's revenue for the twelve months ending Sep 30, 2026 was $299.57M, down 30.3% year over year. For fiscal 2025 it was $385.79M, down 36.0% from the year before. Over ten years it grew 3.5% a year on average. The highest annual figure on record is $1.60B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$385.79M-36.0%
FY2024Dec 31, 2024$602.46M-43.8%
FY2023Dec 31, 2023$1.07B-32.9%
FY2022Dec 31, 2022$1.60B+4.8%
FY2021Dec 31, 2021$1.53B+63.2%
FY2020Dec 31, 2020$934.84M+31.0%
FY2019Dec 31, 2019$713.67M+42.4%
FY2018Dec 31, 2018$501.00M+66.1%
FY2017Dec 31, 2017$301.56M+9.8%
FY2016Dec 31, 2016$274.53M+0.6%
FY2015Dec 31, 2015$272.77M-4.4%
FY2014Dec 31, 2014$285.29M-12.0%
FY2013Dec 31, 2013$324.05M+1.7%
FY2012Dec 31, 2012$318.57M+6.8%
FY2011Dec 31, 2011$298.19M+15.8%
FY2010Dec 31, 2010$257.55M+51.7%
FY2009Dec 31, 2009$169.74M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$72.05M-19.4%
Q2 FY2026Jun 30, 2026$76.38M-27.6%
Q1 FY2026Mar 31, 2026$76.04M-34.3%
Q4 FY2025Dec 31, 2025$75.10M-36.9%
Q3 FY2025Sep 30, 2025$89.41M-36.2%
Q2 FY2025Jun 30, 2025$105.56M-37.4%
Q1 FY2025Mar 31, 2025$115.73M-33.8%
Q4 FY2024Dec 31, 2024$119.00M-37.7%
Q3 FY2024Sep 30, 2024$140.16M-40.6%
Q2 FY2024Jun 30, 2024$168.56M-43.1%
Q1 FY2024Mar 31, 2024$174.74M-49.9%
Q4 FY2023Dec 31, 2023$191.02M-43.4%
Q3 FY2023Sep 30, 2023$235.87M-39.6%
Q2 FY2023Jun 30, 2023$296.19M-34.7%
Q1 FY2023Mar 31, 2023$348.98M-16.4%
Q4 FY2022Dec 31, 2022$337.25M-10.7%
Q3 FY2022Sep 30, 2022$390.40M-5.6%
Q2 FY2022Jun 30, 2022$453.33M+15.0%
Q1 FY2022Mar 31, 2022$417.60M+22.6%
Q4 FY2021Dec 31, 2021$377.83M+42.6%
Q3 FY2021Sep 30, 2021$413.40M+52.3%
Q2 FY2021Jun 30, 2021$394.19M+79.2%
Q1 FY2021Mar 31, 2021$340.67M+90.9%
Q4 FY2020Dec 31, 2020$264.91M+55.3%
Q3 FY2020Sep 30, 2020$271.47M+42.8%
Q2 FY2020Jun 30, 2020$220.00M+17.6%
Q1 FY2020Mar 31, 2020$178.46M+7.6%
Q4 FY2019Dec 31, 2019$170.63M+17.0%
Q3 FY2019Sep 30, 2019$190.06M+36.5%
Q2 FY2019Jun 30, 2019$187.10M+59.5%
Q1 FY2019Mar 31, 2019$165.88M+68.2%
Q4 FY2018Dec 31, 2018$145.84M+87.0%
Q3 FY2018Sep 30, 2018$139.24M+80.3%
Q2 FY2018Jun 30, 2018$117.32M+54.9%
Q1 FY2018Mar 31, 2018$98.60M+39.6%
Q4 FY2017Dec 31, 2017$78.01M+24.9%
Q3 FY2017Sep 30, 2017$77.21M–
Q2 FY2017Jun 30, 2017$75.73M–
Q1 FY2017Mar 31, 2017$70.62M–
Q4 FY2016Dec 31, 2016$62.47M–

More Medifast figures

See a number that looks wrong?